Format

Send to

Choose Destination
Neuropediatrics. 2014 Oct;45(5):294-308. doi: 10.1055/s-0034-1387818. Epub 2014 Sep 4.

Use of intrathecal baclofen in children and adolescents: interdisciplinary consensus table 2013.

Author information

1
Department of Paediatric Neurology and Rehabilitation, Epilepsy Center for Children and Adults, Schön Clinic Vogtareuth, Vogtareuth, Germany.
2
Neuropaediatric Outpatient Center, Children's Hospital Auf Der Bult, Hannover, Germany.
3
Department of Anaesthesia, Children's Intensive Care and Emergency Medicine, Children's Hospital Auf Der Bult, Hannover, Germany.
4
Neuropaediatric Outpatient Clinic, Kinderzentrum St. Martin, Regensburg, Germany.
5
Neurosurgery Department, University Hospital Regensburg, Regensburg, Germany.
6
Neuropaediatric Outpatient Clinic, Sana Hospital, Berlin-Lichtenberg, Germany.
7
Department of Neurosurgery, Schön Clinic Vogtareuth, Vogtareuth, Germany.
8
Department of Children's Surgery, Children's Hospital Auf Der Bult, Hannover, Germany.
9
Department of Neurosurgery, Munich University, Munich, Germany.
10
Children's Hospital, St. Vinzenz Hospital, Zams, Austria.
11
Department of Paediatric Neurology and Developmental Medicine, Dr. von Hauners Children's Hospital, University of Munich, Munich, Germany.
12
Gait Laboratory, Motion Analysis and Therapy, Havixbeck, Germany.
13
Department of Paediatric Neurology, Kassel Hospital, Kassel, Germany.
14
Department of Neurosurgery, Kassel Hospital, Kassel, Germany.
15
KBO Children's Centre, Munich, Germany.

Abstract

In recent years, intrathecal baclofen (ITB) has attained an important role in the treatment of severe spasticity and dystonia in children. There are principal differences between the use of ITB in children and its use in neurology and oncology in adults. Here, we present a consensus report on best practice for the treatment of severe spastic and dystonic movement disorders with ITB. Using a problem-orientated approach to integrate theories and methods, the consensus was developed by an interdisciplinary group of experienced ITB users and experts in the field of movement disorders involving 14 German centers. On the basis of the data pooled from more than 400 patients, the authors have summarized their experience and supporting evidence in tabular form to provide a concise, but still a comprehensive information base that represents our current understanding regarding ITB treatment options in children and adolescents.

PMID:
25188830
DOI:
10.1055/s-0034-1387818
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Georg Thieme Verlag Stuttgart, New York
Loading ...
Support Center